Beyond Autoantibodies: Biologic Roles of Human Autoreactive B Cells in Rheumatoid Arthritis Revealed by RNA-Sequencing.


Journal

Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795

Informations de publication

Date de publication:
04 2019
Historique:
received: 10 05 2018
accepted: 01 11 2018
pubmed: 9 11 2018
medline: 28 12 2019
entrez: 9 11 2018
Statut: ppublish

Résumé

To obtain the comprehensive transcriptome profile of human citrulline-specific B cells from patients with rheumatoid arthritis (RA). Citrulline- and hemagglutinin-specific B cells were sorted by flow cytometry using peptide-streptavidin conjugates from the peripheral blood of RA patients and healthy individuals. The transcriptome profile of the sorted cells was obtained by RNA-sequencing, and expression of key protein molecules was evaluated by aptamer-based SOMAscan assay and flow cytometry. The ability of these proteins to effect differentiation of osteoclasts and proliferation and migration of synoviocytes was examined by in vitro functional assays. Citrulline-specific B cells, in comparison to citrulline-negative B cells, from patients with RA differentially expressed the interleukin-15 receptor α (IL-15Rα) gene as well as genes related to protein citrullination and cyclic AMP signaling. In analyses of an independent cohort of cyclic citrullinated peptide-seropositive RA patients, the expression of IL-15Rα protein was enriched in citrulline-specific B cells from the patients' peripheral blood, and surprisingly, all B cells from RA patients were capable of producing the epidermal growth factor ligand amphiregulin (AREG). Production of AREG directly led to increased migration and proliferation of fibroblast-like synoviocytes, and, in combination with anti-citrullinated protein antibodies, led to the increased differentiation of osteoclasts. To the best of our knowledge, this is the first study to document the whole transcriptome profile of autoreactive B cells in any autoimmune disease. These data identify several genes and pathways that may be targeted by repurposing several US Food and Drug Administration-approved drugs, and could serve as the foundation for the comparative assessment of B cell profiles in other autoimmune diseases.

Identifiants

pubmed: 30407753
doi: 10.1002/art.40772
pmc: PMC6741783
mid: NIHMS995939
doi:

Substances chimiques

Autoantibodies 0
Cytokines 0
IL15RA protein, human 0
Receptors, Interleukin-15 0
EGFR protein, human EC 2.7.10.1
ErbB Receptors EC 2.7.10.1

Banques de données

GENBANK
['GSE99006']

Types de publication

Evaluation Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

529-541

Subventions

Organisme : Cancer Prevention and Research Institute of Texas
ID : RP130570
Pays : International
Organisme : United States Department of Defense
ID : CA160591
Pays : International
Organisme : NCI NIH HHS
ID : R01 CA174385
Pays : United States
Organisme : Cancer Prevention and Research Institute of Texas
ID : RP180466
Pays : International
Organisme : Welch Foundation
ID : E-1774
Pays : International
Organisme : National Science Foundation
ID : 1705464
Pays : International
Organisme : Melanoma Research Alliance
ID : 509800
Pays : International

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018, American College of Rheumatology.

Références

Immunol Rev. 2010 Jan;233(1):233-55
pubmed: 20193003
Rheumatology (Oxford). 2014 Feb;53(2):260-9
pubmed: 24196392
J Biomed Biotechnol. 2011;2011:830421
pubmed: 21716666
J Immunol. 2012 Apr 1;188(7):3513-21
pubmed: 22393153
Springer Semin Immunopathol. 2006 Dec;28(4):339-50
pubmed: 17043867
Arthritis Rheumatol. 2014 Jan;66(1):60-7
pubmed: 24449576
Nature. 2017 Feb 1;542(7639):110-114
pubmed: 28150777
Nat Immunol. 2011 Aug 28;12(10):1002-9
pubmed: 21874024
Sci Rep. 2016 Jul 07;6:29338
pubmed: 27385284
J Immunol. 2001 Jul 15;167(2):1072-80
pubmed: 11441118
Arthritis Rheum. 2005 Sep;52(9):2686-92
pubmed: 16142748
Nat Rev Rheumatol. 2016 Jan;12(1):49-62
pubmed: 26656660
Immunity. 2015 Feb 17;42(2):216-226
pubmed: 25692699
Ann Rheum Dis. 2016 Jun;75(6):1170-6
pubmed: 26034045
J Exp Med. 2012 May 7;209(5):1001-10
pubmed: 22547654
Immunol Rev. 2010 Sep;237(1):55-71
pubmed: 20727029
Nat Genet. 2012 Dec;44(12):1336-40
pubmed: 23143596
Nat Rev Immunol. 2007 Jun;7(6):429-42
pubmed: 17525752
Science. 1997 Apr 25;276(5312):596-9
pubmed: 9110979
J Immunol. 2010 Jul 1;185(1):23-7
pubmed: 20519654
Nat Rev Immunol. 2007 Dec;7(12):923-7
pubmed: 17965637
Cell Mol Life Sci. 2008 May;65(10):1566-84
pubmed: 18259690
Semin Cell Dev Biol. 2014 Apr;28:31-41
pubmed: 24463227
J Inflamm (Lond). 2008 Apr 27;5:5
pubmed: 18439312
J Investig Dermatol Symp Proc. 2013 Dec;16(1):S28-30
pubmed: 24326545
Arthritis Rheum. 2009 Aug;60(8):2232-41
pubmed: 19644872
Crit Rev Immunol. 2010;30(5):463-87
pubmed: 21083527
Arthritis Rheumatol. 2016 Apr;68(4):805-16
pubmed: 26554541
BMC Musculoskelet Disord. 2015 Mar 12;16:51
pubmed: 25879761
Clin Rev Allergy Immunol. 2013 Oct;45(2):170-9
pubmed: 23288628
J Clin Invest. 2012 May;122(5):1791-802
pubmed: 22505457
Microarrays (Basel). 2015 Sep 22;4(3):424-31
pubmed: 27600232
J Immunol. 2015 Feb 1;194(3):1039-46
pubmed: 25556244
Arthritis Rheum. 2011 Dec;63(12):3681-91
pubmed: 22127691
Ann Rheum Dis. 1990 Sep;49(9):665-7
pubmed: 1700672
Arthritis Res Ther. 2011 Feb 03;13(1):R13
pubmed: 21291540
J Immunol. 2001 Oct 1;167(7):4067-74
pubmed: 11564828
Nat Rev Rheumatol. 2009 Aug;5(8):433-41
pubmed: 19581902
Ann Rheum Dis. 2015 Mar;74(3):579-86
pubmed: 24297382
Biochemistry. 2006 Apr 4;45(13):4093-104
pubmed: 16566583
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2840-4
pubmed: 7708734
Rheumatology (Oxford). 2008 Apr;47(4):409-14
pubmed: 18187523
Blood. 2003 Jul 15;102(2):592-600
pubmed: 12663452
Bioinformatics. 2017 Nov 1;33(21):3486-3488
pubmed: 29036287
J Immunol. 2001 Oct 15;167(8):4710-8
pubmed: 11591802
Arthritis. 2012;2012:943156
pubmed: 22888423
EMBO J. 1998 Oct 1;17(19):5734-43
pubmed: 9755173
Genes Cancer. 2012 Feb;3(2):117-30
pubmed: 23050044
Biochim Biophys Acta. 2013 Oct;1829(10):1126-35
pubmed: 23860259
Ann Rheum Dis. 2007 Jun;66(6):818-20
pubmed: 17148544

Auteurs

Ankit Mahendra (A)

University of Houston, Houston, Texas.

Xingyu Yang (X)

Georgia Institute of Technology, Atlanta.

Shaza Abnouf (S)

University of Houston, Houston, Texas.

Jay R T Adolacion (JRT)

University of Houston, Houston, Texas.

Daechan Park (D)

Ajou University, Suwon, Republic of Korea.

Sanam Soomro (S)

University of Houston, Houston, Texas.

Jason Roszik (J)

University of Texas MD Anderson Cancer Center, Houston.

Cristian Coarfa (C)

Baylor College of Medicine, Houston, Texas.

Gabrielle Romain (G)

University of Houston, Houston, Texas.

Keith Wanzeck (K)

University of Alabama at Birmingham.

S Louis Bridges (SL)

University of Alabama at Birmingham.

Amita Aggarwal (A)

Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

Peng Qiu (P)

Georgia Institute of Technology, Atlanta.

Sandeep K Agarwal (SK)

Baylor College of Medicine, Houston, Texas.

Chandra Mohan (C)

University of Houston, Houston, Texas.

Navin Varadarajan (N)

University of Houston, Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH